Daily digest · Mon · 21 Sep 2026

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.

🔴🟠 HIGH PRIORITY (8+ OR PRIORITY FLAG) — Best Finds by Topic

Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk

PM42763732/PMID 42763732 · Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials. · 8/10 · The randomized-trial meta-analysis addresses a large cardiometabolic population and reports clinically relevant outcomes, with heterogeneity tempering confidence. PM42764072/PMID 42764072 · Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study. · 8/10 · The exceptionally large comparative cohort has near-term clinical relevance, but its observational design precludes causal claims.

Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)

PM42764148/PMID 42764148 · Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups. · 8/10 · A phase III randomized trial provides direct clinical evidence in a watchlist malignancy, with a meaningful progression-free survival result but no overall-survival benefit. PM42764087/PMID 42764087 · Leukemic Stem Cell-Targeted Liposomal Nanoimmunotherapy Reverses Immune Evasion and Inhibits Fusion Oncoprotein-Driven Acute Myeloid Leukemia by Silencing B-Cell Lymphoma 2. · 5/10 · The work presents a novel targeted treatment concept for acute myeloid leukemia, but the non-human evidence is conservatively capped at five.

Early cancer detection (liquid biopsy, ctDNA, cfDNA)

PM42763649/PMID 42763649 · ctDNA in the Management of Resectable & Advanced Colorectal Cancer: Current Status and Future Directions. · 7/10 · The article is highly relevant to liquid-biopsy surveillance and carefully separates prognostic validity from proven clinical utility, but it is a review rather than new prospective evidence. PM42763843/PMID 42763843 · Predictors of perceived value of multi-cancer early detection testing: a national PRECEDE-PROCEED framework study. · 7/10 · The study directly addresses implementation of multi-cancer early detection in a large national sample, but it measures perceptions rather than diagnostic or patient outcomes.

Novel therapeutics: immunotherapy, CAR-T, targeted therapy

PM42764195/PMID 42764195 · Cord Blood-Derived Fibroblast Activation Protein-Targeted Chimeric Antigen Receptor Natural Killer Cells Persist in Vivo. · 5/10 · This is a novel cellular-therapy platform with clear target engagement, but efficacy remains preclinical and incomplete, so the score is capped at five.

CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best candidate scored 0/10).

AI/ML in clinical diagnostics and imaging: No high-priority finds today (best candidate scored 7/10).

Precision oncology and genomic medicine: No high-priority finds today (best candidate scored 7/10).

Aging, longevity, and population health: No high-priority finds today (best candidate scored 5/10).

Rare diseases with high unmet need: No high-priority finds today (best candidate scored 6/10).

🟢⚪ STANDARD (5-7) — Top by Topic

AI/ML in clinical diagnostics and imaging

PM42763426/PMID 42763426 · An Artificial Intelligence-Based Preoperative Planning System for High Tibial Osteotomy Significantly Enhances Planning Speed With Comparable Accuracy to Surgeons. · 7/10 · Diagnostics PM42763871/PMID 42763871 · Postoperative Supraspinatus Muscle Volume Restoration Is Associated With Tendon Healing and Strength Recovery After Rotator Cuff Repair: Deep-Learning-Based Volumetric Analysis of the Entire Muscle With Clinical Correlation. · 6/10 · Diagnostics PM42763979/PMID 42763979 · CReaTe-LM: A large language model for stepwise, heuristic clinical reasoning instruction. · 6/10 · Diagnostics PM42763524/PMID 42763524 · Single-cell sequencing-guided discovery of narciclasine as a dual VCAM-1/ICAM-1 inhibitor for atherosclerosis management. · 5/10 · Drug Development PM42763991/PMID 42763991 · Development and evaluation of a combined machine learning model for the prediction of acute GU toxicity in prostate cancer radiotherapy. · 5/10 · Diagnostics

Precision oncology and genomic medicine

PM42764109/PMID 42764109 · Precision oncology in GI-cancers: Mechanisms of action, indications and ongoing strategies to overcome primary and secondary resistance. · 7/10 · Genomics/Precision Medicine PM42764221/PMID 42764221 · [Clinicopathological, molecular characteristics and prognostic analysis of non-small cell lung cancer with HER-2 genetic variations]. · 7/10 · Genomics/Precision Medicine PM42764181/PMID 42764181 · A Seamless Phase I/II Design With Randomization for Biomarker-Guided Oncology Trials. · 5/10 · Drug Development

Novel therapeutics: immunotherapy, CAR-T, targeted therapy

Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk

PM42763716/PMID 42763716 · Comparative Incidence of Urinary Tract Infections in Diabetic Women Treated with Dapagliflozin Versus Empagliflozin: A Double-Blind Randomized Clinical Trial. · 7/10 · Treatment Innovation PM42764204/PMID 42764204 · Quantitative Insights into Tirzepatide and Semaglutide Using Longitudinal Systems Modeling. · 6/10 · Drug Development

Aging, longevity, and population health

PM42764149/PMID 42764149 · Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer's Disease, Late-Life Depression, and Healthy Aging: A Preliminary Cross-Sectional Study. · 5/10 · Diagnostics

Rare diseases with high unmet need

PM42763903/PMID 42763903 · Leveraging external control for accelerating development: A case study from cell gene therapy in Duchenne muscular dystrophy. · 6/10 · Drug Development

💡 UNSOLICITED FINDS

PM42763546/PMID 42763546 · LAMA5 pathogenic variant uncovers a novel autoantigen in membranous nephropathy. · 6/10 · Genomics/Precision Medicine PM42763547/PMID 42763547 · Patient and healthcare professional perceptions of weight reduction in the treatment of knee osteoarthritis: A systematic literature review. · 6/10 · Public Health

📊 TODAY'S BREAKDOWN

By research category: Treatment Innovation 4 | Public Health 2 | Diagnostics 5 | Early Detection 2 | Genomics/Precision Medicine 3 | Drug Development 5
By evidence maturity: Validated 6 | Exploratory 15
By watchlist topic:
- Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): 13 reviewed / 2 kept / highest 8
- CBC-based diagnostics and machine learning in hematology: 0 reviewed / 0 kept / highest 0
- Early cancer detection (liquid biopsy, ctDNA, cfDNA): 3 reviewed / 2 kept / highest 7
- AI/ML in clinical diagnostics and imaging: 15 reviewed / 5 kept / highest 7
- Precision oncology and genomic medicine: 15 reviewed / 3 kept / highest 7
- Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 3 kept / highest 7
- Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 13 reviewed / 4 kept / highest 8
- Aging, longevity, and population health: 4 reviewed / 1 kept / highest 5
- Rare diseases with high unmet need: 3 reviewed / 1 kept / highest 6
- Sentinel: 10 reviewed / 3 kept / highest 6
By source type: peer_reviewed 21 | preprint 0
Topics with zero HIGH-priority articles this run: CBC-based diagnostics and machine learning in hematology; AI/ML in clinical diagnostics and imaging; Precision oncology and genomic medicine; Aging, longevity, and population health; Rare diseases with high unmet need

🔧 RUN NOTES

Complete rerun coverage was regenerated; prior same-day emission did not remove articles.
CBC/ML primary and fallback queries both returned zero candidates.
AI/ML, precision-oncology, novel-therapeutics, and sentinel searches hit their review caps.
Abstract retrieval used verified PubMed EFetch responses; truncated batches were retried successfully in abstract mode.
No Telegram alerts were emitted from this attempt.